FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells

Bibliographic Details
Title: FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells
Authors: Jin‐Li Li, Jian‐Ping Wang, Hong Chang, Sheng‐Ming Deng, Jia‐Hui Du, Xiao‐Xiao Wang, He‐Juan Hu, Dong‐Yin Li, Xiang‐Bin Xu, Wei‐Qiang Guo, Yao‐Hua Song, Zhigang Guo, Min‐Xuan Sun, Yi‐Wei Wu, Song‐Bai Liu
Source: Cancer Medicine, Vol 8, Iss 18, Pp 7774-7780 (2019)
Publisher Information: Wiley, 2019.
Publication Year: 2019
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: cervical cancer, FEN1, radiotherapy, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background Cervical cancer is one of the most common causes of cancer‐associated mortality among affected women in the world. At present, treatment with weekly cisplatin plus ionizing radiation (IR) therapy is the standard regimen for cervical cancer, especially for locally advanced cervical cancer. The purpose of this study is to determine whether FEN1 inhibitors could enhance the therapeutic effect of IR therapy. Methods Western blot was applied to determine the expression of FEN1‐ and apoptosis‐related proteins. Cell growth inhibition assay and colony formation assay were used to determine the effects of FEN1 inhibitor and IR exposure for Hela cells in vitro. CRISPR technology was used to knockdown FEN1 expression level of 293T cells, and tumor xenograft in nude mice was employed to determine the effects of FEN1 inhibitor and IR exposure on tumor growth in vivo. Results Our data revealed that FEN1 is overexpressed in HeLa cell and can be upregulated further by IR. We also demonstrated that FEN1 inhibitor enhances IR sensitivity of cervical cancer in vitro and in vivo. Conclusion FEN1 inhibitor SC13 could sensitize radiotherapy of cervical cancer cell.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-7634
Relation: https://doaj.org/toc/2045-7634
DOI: 10.1002/cam4.2615
Access URL: https://doaj.org/article/d6b59cec6b334666bb97c016552c2a22
Accession Number: edsdoj.6b59cec6b334666bb97c016552c2a22
Database: Directory of Open Access Journals
More Details
ISSN:20457634
DOI:10.1002/cam4.2615
Published in:Cancer Medicine
Language:English